
Is Abbott Labs Stock a Buy, Sell or Hold?
The degree to which the healthcare paradigm has changed is…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Income Statement | ||||||
Revenue | $1.3B | $1.5B | $1.6B | $356.8M | $370.7M | |
Gross Profit | $465.5M | $648.1M | $707M | $155.9M | $161.2M | |
Operating Income | $122.5M | $218.1M | $258.1M | $47.6M | $53.1M | |
EBITDA | $165.2M | $273.2M | $328.4M | $51.6M | $72.4M | |
Diluted EPS | $0.49 | $0.65 | $0.92 | $0.08 | $0.21 |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | -- | $474.8M | $757.5M | $667.8M | $722.1M | |
Total Assets | -- | $1.1B | $2.9B | $2.7B | $2.6B | |
Current Liabilities | -- | $240.4M | $289.3M | $220.9M | $247.8M | |
Total Liabilities | -- | $951.3M | $1.2B | $1.1B | $1.1B | |
Total Equity | -- | $126.4M | $1.6B | $1.6B | $1.6B | |
Total Debt | -- | $539.5M | $535.3M | $473.6M | $475M |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Cash Flow Statement | ||||||
Cash Flow Operations | $97M | $253.9M | $293.5M | $58.2M | $63.6M | |
Cash From Investing | -$6.6M | -$4.6M | -$20.2M | $2M | -$9.1M | |
Cash From Financing | -$61.1M | -$239.2M | -$207.5M | -$97.7M | -$41.7M | |
Free Cash Flow | $89.4M | $232.6M | $271.7M | $52.8M | $54.5M |
Zurn Elkay Water Solutions Corp designs procures, manufactures, and markets a range of clean water solutions for drinking water, hygiene, and sustainable water management. The company's product portfolio includes professional-grade water control and safety, water distribution and drainage, drinking water, finish plumbing, hygienic, environmental and site works products for public and private spaces.
In the current month, ZWS has received 2 Buy ratings 5 Hold ratings, and 0 Sell ratings. The ZWS average analyst price target in the past 3 months is $40.57.
According to analysts, the consensus estimate is that Zurn Elkay Water Solutions share price will rise to $40.57 per share over the next 12 months.
Analysts are divided on their view about Zurn Elkay Water Solutions share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Zurn Elkay Water Solutions is a Sell and believe this share price will drop from its current level to $37.00.
The price target for Zurn Elkay Water Solutions over the next 1-year time period is forecast to be $40.57 according to 7 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Zurn Elkay Water Solutions is a Hold. 5 of 7 analysts rate the stock a Hold at this time.
You can purchase shares of Zurn Elkay Water Solutions via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Zurn Elkay Water Solutions shares.
Zurn Elkay Water Solutions was last trading at $34.84 per share. This represents the most recent stock quote for Zurn Elkay Water Solutions. Yesterday, Zurn Elkay Water Solutions closed at $34.88 per share.
In order to purchase Zurn Elkay Water Solutions stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
The degree to which the healthcare paradigm has changed is…
While the world focuses on AI, the leaders over at…
Conagra Brands (NYSE:CAG) is a major producer of prepared meals,…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.3T
P/E Ratio: 113x
Market Cap: $3T
P/E Ratio: 35x
Globant SA [GLOB] is up 1.57% over the past day.
Celsius Holdings [CELH] is down 3.77% over the past day.
Hims & Hers Health [HIMS] is up 4.28% over the past day.